Showing results (91-100 of 192) with videos related to
Sort By:
Pageof 20
Journal of Clinical Pharmacy and Therapeutics|August 7, 1999
Comparative bioavailability of three different preparations of rifampicinR Pähkla, J Lambert, P Ansko, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 10, 2010
Bioactivation and bioinactivation of drugs and drug metabolites: Relevance to adverse drug reactionsB K Park, M Pirmohamed, M D Tingle, et al.British Journal of Clinical Pharmacology|September 1, 1996
The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazoleH J Gill, J L Maggs, S Madden, et al.European Journal of Clinical Investigation|December 12, 2001
Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery diseaseR A Allen, E M Lee, D H Roberts, et al.Clinical Pharmacology and Therapeutics|October 21, 2011
A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapyP J Avery, A Jorgensen, A K Hamberg, et al.British Journal of Clinical Pharmacology|April 1, 1995
Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer's patients with tacrine transaminitisV J Green, M Pirmohamed, N R Kitteringham, et al.Journal of Internal Medicine|October 24, 2014
Personalized medicine approaches in epilepsyL E Walker, N Mirza, V L M Yip, et al.British Journal of Clinical Pharmacology|April 25, 2001
Carbamazepine is not a substrate for P-glycoproteinA Owen, M Pirmohamed, J N Tettey, et al.Chemical Research in Toxicology|August 21, 2001
Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivoJ N Tettey, J L Maggs, W G Rapeport, et al.International Journal of Clinical Practice|July 22, 2005
Carbamazepine-induced acute liver failure as part of the DRESS syndromeW-K Syn, D J Naisbitt, A P Holt, et al.Pageof 20